Skip to main content

Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

Cancer Chemotherapy and Pharmacology volume 35, pages 297–303 (1995)Cite this article

Abstract

The kinetics of taxol-induced mitotic arrest and apoptosis in murine mammary carcinoma MCA-4 and ovarian carcinoma OCA-I tumors were determined to establish a possible causative relationship between mitotic arrest and apoptosis and to see whether these cellular effects of taxol would correlate with the extent of its antitumor efficacy. Mice bearing 8-mm tumors in a hind leg were given taxol i.v. at a dose of 10–80 mg/kg. Both tumors responded to taxol by significant growth delay or transient regression; in general, the response was greater as the dose of taxol was increased. For kinetics studies the mice were treated with 60 mg/kg taxol given once when tumors were 8 mm in size or twice, with the second dose being given 3 days after the first. At various times ranging from 1 to 96 h after treatment with taxol, tumors were histologically analyzed to quantify mitotic and apoptotic activity. After a single dose of taxol, mitotic arrest was visible at 1 h, and the mitotic index increased with time to reach peak values of 36% in MCA-4 tumors and 22% in OCA-I tumors at 9 h. The index then declined to a baseline of 1%–3% at 3 days for MCA-4 tumors and 1 day for OCA-I tumors. Apoptosis followed mitotic arrest, beginning at the time of peak mitotic arrest, increasing to the highest level of about 20% at 18–24 h after treatment and gradually declining to the normal level of 3%–6% after 3–4 days. Nuclear material progressively condensed in mitotically arrested cells, culminating in the frank appearance of multiple apoptotic bodies. The change in cell morphology plus the dynamics of apoptosis development imply that a large percentage of tumor cells arrested in mitosis by taxol die by apoptosis. Kinetic analysis undertaken after the second dose of taxol showed a considerably lower percentage of cells arrested in mitosis as compared with that seen after a single dose, and the induction of apoptosis by the second dose was minimal. However, the antitumor efficacy of the second dose of taxol was similar to or better than that of the first dose, implying that in addition to mitotic arrest and apoptosis, there exist other mechanisms by which taxol exerts its antitumor action.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Bhalla K, Ilerado AM, Tourkina E, Tang C, Mahoney ME, Huang Y (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563–568

    CAS  PubMed  Google Scholar 

  2. Dive C, Evans CA, Whitton AD (1992) Induction of apoptosis—new targets for cancer chemotherapy. Semin Cancer Biol 3: 417–427

    CAS  PubMed  Google Scholar 

  3. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, Peters L (1993) Heterogeneity in apoptosis development in irradiated murine tumors. Int J Radiat Biol 64:583–591

    CAS  Article  PubMed  Google Scholar 

  4. Meyn RE, Stephens LC, Milas L, Ang KK, Hunter NR (1993) Apoptosis development in murine solid tumors treated in vivo with cyclophosphamide or cisplatin. Proc Am Assoc Cancer Res 34:287

    Google Scholar 

  5. Meyn RE, Stephens LC, Hunter NR, Milas L (1994) Induction of apoptosis in murine tumors by cyclophosphamide. Cancer Chemother Pharmacol 33(5):410–414

    CAS  Article  PubMed  Google Scholar 

  6. Milas L, Hunter N, Mason K, Withers HR (1974) Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res 34:61–71

    CAS  PubMed  Google Scholar 

  7. Rose WC (1992) Taxol: a review of its preclinical in vivo antitumor activity. Anticancer Drugs 3:311–321

    CAS  Article  PubMed  Google Scholar 

  8. Rowinsky EK, Donehower RC, Jones RJ, Tucker RW (1988) Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 48:4093–4100

    CAS  PubMed  Google Scholar 

  9. Rowinsky EK, Onetto N, Canetta RM, Arbuck SG (1992) Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19:646–662

    CAS  PubMed  Google Scholar 

  10. Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561–1565

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667

    CAS  Article  PubMed  Google Scholar 

  12. Stephens LC, Ang KK, Schulthesis TE, Milas L, Meyn RE (1991) Apoptosis in irradiated murine tumors. Radiat Res 127:308–316

    CAS  Article  PubMed  Google Scholar 

  13. Stephens LC, Hunter NR, Ang KK, Milas L, Meyn RE (1993) Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 135:75–80

    CAS  Article  PubMed  Google Scholar 

  14. Tishler RB, Geard CR, Hall EJ, Schiff PB (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495–3497

    CAS  PubMed  Google Scholar 

  15. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556

    CAS  Article  PubMed  Google Scholar 

  16. Wyllie AH (1992) Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11:95–103

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Experimental Radiotherapy (66), The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, TX, USA

    Luka Milas, Nancy R. Hunter, Belma Kurdoglu, Kathryn A. Mason & Raymond E. Meyn

  2. Department of Veterinary Medicine and Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    L. C. Stephens

  3. Department of Clinical Radiotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    Lester J. Peters

Authors
  1. Luka Milas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy R. Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Belma Kurdoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kathryn A. Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raymond E. Meyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. C. Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lester J. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Milas, L., Hunter, N.R., Kurdoglu, B. et al. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35, 297–303 (1995). https://doi.org/10.1007/BF00689448

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689448

Key words

  • Taxol
  • Mitotic arrest
  • Apoptosis